The therapeutic potential of berberine chloride against SARM1 ‐dependent axon degeneration in acrylamide‐induced neuropathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The therapeutic potential of berberine chloride against
SARM1
‐dependent axon degeneration in acrylamide‐induced neuropathy
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-08-30
DOI
10.1002/ptr.7594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
- (2022) A. Joseph Bloom et al. Molecular Neurodegeneration
- SARM1 can be a potential therapeutic target for spinal cord injury
- (2022) Qicheng Lu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
- (2021) Robert O. Hughes et al. Cell Reports
- Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression
- (2021) Giulia Vanti et al. Pharmaceutics
- Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
- (2021) Todd Bosanac et al. BRAIN
- Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures
- (2021) Donald V. Bradshaw et al. Acta Neuropathologica Communications
- Intra-Herb Interactions: Primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice
- (2021) Jing Zhao et al. Frontiers in Pharmacology
- A Review of Dietary Intake of Acrylamide in Humans
- (2021) Clara Amalie Gade Timmermann et al. Toxics
- Oral administration of berberine limits post-traumatic osteoarthritis development and associated pain via AMP-activated protein kinase (AMPK) in mice
- (2021) J. Li et al. OSTEOARTHRITIS AND CARTILAGE
- Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration
- (2021) Stacey Anne Gould et al. Cell Reports
- Acrylamide in coffee: formation and possible mitigation strategies – a review
- (2020) Maria Alessia Schouten et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Nanoparticles based on complex of berberine chloride and polymethacrylic or polyacrylic acid with antioxidant and in vitro antitumor activities
- (2020) Nikoleta Stoyanova et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Berberine mitigates oxidative damage associated with testicular impairment following mercury chloride intoxication
- (2020) Gadah Albasher et al. JOURNAL OF FOOD BIOCHEMISTRY
- Identification of the first noncompetitive SARM1 inhibitors
- (2020) Heather S. Loring et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Berberine and barberry (Berberis vulgaris ): A clinical review
- (2019) Mohsen Imenshahidi et al. PHYTOTHERAPY RESEARCH
- Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration
- (2019) Andrea Loreto et al. NEUROBIOLOGY OF DISEASE
- Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride
- (2019) Giulia Vanti et al. Pharmaceutics
- Sulfonato-β-Cyclodextrin Mediated Supramolecular Nanoparticle for Controlled Release of Berberine
- (2018) Xu-Man Chen et al. ACS Applied Materials & Interfaces
- Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: Optimization and pharmacokinetics
- (2018) Manal A Elsheikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models
- (2018) Manal A. Elsheikh et al. PHARMACEUTICAL RESEARCH
- Male germ cells support long-term propagation of Zika virus
- (2018) Christopher L. Robinson et al. Nature Communications
- Preparation and in vitro-in vivo evaluation of intestinal retention pellets of Berberine chloride to enhance hypoglycemic and lipid-lowing efficacy
- (2018) Guofei Li et al. Asian Journal of Pharmaceutical Sciences
- Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction
- (2017) Iris E. Allijn et al. JOURNAL OF CONTROLLED RELEASE
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- Sarm1 Deletion, but Not Wld S , Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
- (2017) Jonathan Gilley et al. Cell Reports
- Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma
- (2017) Lili Sun et al. Pharmaceutics
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- (2016) Stefanie Geisler et al. BRAIN
- Delivery system for berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: Physicochemical characterization, release behavior and evaluation of anti-bacterial potential
- (2016) Mohamed Amine Djebbi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism
- (2016) Josiah Gerdts et al. NEURON
- The Role of Berberine in the Multi-Target Treatment of Senile Dementia
- (2015) Min Huang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis
- (2015) Yan Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor
- (2015) Zohreh Vaziri et al. NEUROSCIENCE LETTERS
- SARM1 activation triggers axon degeneration locally via NAD+ destruction
- (2015) J. Gerdts et al. SCIENCE
- The potential effect of berberine in mercury-induced hepatorenal toxicity in albino rats
- (2014) Mohamed S. Othman et al. FOOD AND CHEMICAL TOXICOLOGY
- Berberine, an Epiphany Against Cancer
- (2014) Luis Guamán Ortiz et al. MOLECULES
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
- (2013) J. Gerdts et al. JOURNAL OF NEUROSCIENCE
- SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria
- (2013) Hitoshi Murata et al. MOLECULAR BIOLOGY OF THE CELL
- Neurotoxicity of Acrylamide in Exposed Workers
- (2013) Manuela Pennisi et al. International Journal of Environmental Research and Public Health
- Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
- (2012) Siva Sundara Kumar Durairajan et al. NEUROBIOLOGY OF AGING
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence
- (2011) Porkodi Panneerselvam et al. BIOCHEMICAL JOURNAL
- Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats
- (2011) Wei Chen et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Preparation and Evaluation of Berberine Alginate Beads for Stomach-Specific Delivery
- (2011) Zhen-Hai Zhang et al. MOLECULES
- Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
- (2010) Jonathan Gilley et al. PLOS BIOLOGY
- Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
- (2009) S. K. Kulkarni et al. PHYTOTHERAPY RESEARCH
- SARM: a novel Toll-like receptor adaptor, is functionally conserved from arthropod to human
- (2007) Loh Wei-Ching Belinda et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started